Goldman Sachs Maintains a 'Buy' on Johnson & Johnson (JNJ); Best/Largest Biotech Play in Global Industry
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Price: $260.35 -0.66%
Rating Summary:
23 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
23 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs maintains a 'Buy' on Johnson & Johnson (NYSE: JNJ), PT $77.
Goldman analyst said, "JNJ’s Pharma Analyst Day reinforced our conviction in JNJ as the best new product story in the global drug sector, given its dominant positions in the largest and fastest growing categories...What is more, JNJ is
stepping into a growth phase in this division while many of the large biotech companies’ growth engines are facing question marks. Based on our sum-of-the-parts analysis the biopharma business could trade at least at 13X and be worth $88 billion – larger than any of the large-cap biotech companies."
For more ratings news on Johnson & Johnson click here and for the rating history of Johnson & Johnson click here.
Shares of Johnson & Johnson closed at $65.51 yesterday.
Goldman analyst said, "JNJ’s Pharma Analyst Day reinforced our conviction in JNJ as the best new product story in the global drug sector, given its dominant positions in the largest and fastest growing categories...What is more, JNJ is
stepping into a growth phase in this division while many of the large biotech companies’ growth engines are facing question marks. Based on our sum-of-the-parts analysis the biopharma business could trade at least at 13X and be worth $88 billion – larger than any of the large-cap biotech companies."
For more ratings news on Johnson & Johnson click here and for the rating history of Johnson & Johnson click here.
Shares of Johnson & Johnson closed at $65.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"
- Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
- New Street Research Upgrades Micron Technology (MU) to Buy
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
